Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 36.03%
March 31, 2026 1.60%
December 31, 2025 -21.14%
September 30, 2025 62.31%
June 30, 2025 21.93%
March 31, 2025 16.20%
December 31, 2024 36.75%
September 30, 2024 5.15%
June 30, 2024 18.31%
March 31, 2024 -13.76%
December 31, 2023 36.80%
September 30, 2023 -24.88%
June 30, 2023 27.08%
March 31, 2023 30.06%
December 31, 2022 11.59%
September 30, 2022 1.21%
June 30, 2022 -44.19%
March 31, 2022 -84.97%
December 31, 2021 -19.22%
September 30, 2021 -17.94%
June 30, 2021 -40.61%
March 31, 2021 -24.46%
December 31, 2020 -163.7%
September 30, 2020 4.82%
June 30, 2020 15.91%
Date Value
March 31, 2020
December 31, 2019 -15.24%
September 30, 2019 -67.81%
June 30, 2019 -100.7%
March 31, 2019 -78.55%
December 31, 2018 -55.94%
September 30, 2018 14.31%
June 30, 2018 -127.2%
March 31, 2018 -1.62K%
December 31, 2017 -451.2%
September 30, 2017 44.35%
June 30, 2017 11.65%
March 31, 2017 -3.06%
December 31, 2016 21.02%
September 30, 2016 21.63%
June 30, 2016 -22.12%
March 31, 2016 -570.8%
December 31, 2015 0.73%
September 30, 2015 -62.74%
June 30, 2015 15.75%
March 31, 2015 19.34%
December 31, 2014 18.10%
September 30, 2014 -8.13%
June 30, 2014 -33.37%
March 31, 2014 0.42%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Evaxion AS --
Genmab A/S 26.23%
Ascendis Pharma A/S 61.00%
Zealand Pharma A/S 87.22%
Agenus, Inc. -1.64%